These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 22008243)

  • 1. Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts.
    van Thriel C; Westerink RH; Beste C; Bale AS; Lein PJ; Leist M
    Neurotoxicology; 2012 Aug; 33(4):911-24. PubMed ID: 22008243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
    Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
    Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children.
    Sachana M; Rolaki A; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():153-175. PubMed ID: 29524501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment.
    Harrill JA; Freudenrich T; Wallace K; Ball K; Shafer TJ; Mundy WR
    Toxicol Appl Pharmacol; 2018 Sep; 354():24-39. PubMed ID: 29626487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
    Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between ketamine-induced developmental neurotoxicity and NMDA receptor-mediated calcium influx in neural stem cell-derived neurons.
    Wang C; Liu F; Patterson TA; Paule MG; Slikker W
    Neurotoxicology; 2017 May; 60():254-259. PubMed ID: 27132109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.
    Vorhees CV; Sprowles JN; Regan SL; Williams MT
    Toxicol Appl Pharmacol; 2018 Sep; 354():176-190. PubMed ID: 29544898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J; Settivari R; LeBaron MJ; Marty MS
    Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNT-EST: a predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro.
    Hayess K; Riebeling C; Pirow R; Steinfath M; Sittner D; Slawik B; Luch A; Seiler AE
    Toxicology; 2013 Dec; 314(1):135-47. PubMed ID: 24096155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
    Terron A; Bennekou SH
    Toxicol Appl Pharmacol; 2018 Sep; 354():19-23. PubMed ID: 29454059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
    Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
    Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotenone exerts developmental neurotoxicity in a human brain spheroid model.
    Pamies D; Block K; Lau P; Gribaldo L; Pardo CA; Barreras P; Smirnova L; Wiersma D; Zhao L; Harris G; Hartung T; Hogberg HT
    Toxicol Appl Pharmacol; 2018 Sep; 354():101-114. PubMed ID: 29428530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system.
    Wang C; Slikker W
    Anesth Analg; 2008 Jun; 106(6):1643-58. PubMed ID: 18499593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying the adverse outcome pathway concept to questions in anaesthetic neurotoxicity.
    Waspe J; Chico TJA; Hansen TG
    Br J Anaesth; 2021 Jun; 126(6):1097-1102. PubMed ID: 33888301
    [No Abstract]   [Full Text] [Related]  

  • 16. Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered.
    Bal-Price AK; Hogberg HT; Buzanska L; Coecke S
    Neurotoxicol Teratol; 2010; 32(1):36-41. PubMed ID: 19150401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept.
    Pistollato F; de Gyves EM; Carpi D; Bopp SK; Nunes C; Worth A; Bal-Price A
    Environ Health; 2020 Feb; 19(1):23. PubMed ID: 32093744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage-specific metabolic features of differentiating neurons: Implications for toxicant sensitivity.
    Delp J; Gutbier S; Cerff M; Zasada C; Niedenführ S; Zhao L; Smirnova L; Hartung T; Borlinghaus H; Schreiber F; Bergemann J; Gätgens J; Beyss M; Azzouzi S; Waldmann T; Kempa S; Nöh K; Leist M
    Toxicol Appl Pharmacol; 2018 Sep; 354():64-80. PubMed ID: 29278688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A locust embryo as predictive developmental neurotoxicity testing system for pioneer axon pathway formation.
    Bode K; Bohn M; Reitmeier J; Betker P; Stern M; Bicker G
    Arch Toxicol; 2020 Dec; 94(12):4099-4113. PubMed ID: 33079231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.